Uh-oh, just as I'm starting to remember to take my calcium daily, I learn this. An Auckland (New Zealand) University study has linked calcium supplements to an increased risk of cardiac disease. The half of postmenopausal women in the control group who took 1 gram of calcium per day had more heart attacks than those taking a placebo. It is... Read more
A new study published online by the New England Journal of Medicine indicates that an intravenous dose of zoledronic acid within 90 days after a hip fracture (and yearly afterward) to reduce the risk of another fracture and death from a fracture. That is tremendous news, since someone who has already suffered such a traumatic experience may not be... Read more
I don't know if this is good news, bad news, or what. Researchers at the University of Milan have been working on the connection between taking your calcium, watching yout weight and your risk of osteoporosis. What they've come up with is this: being overweight is associated with low dairy intake (not good for osteoporosis). But having a... Read more
Zoledronic acid, sold in the U.S. by Novartis under the brand name Reclast, just received final approval from the FDA for the treatment of osteoporosis. The bisphosphonate medication is taken intravenously once a year and has been on the market to treat other bone diseases. Its approval for osteoporosis adds a major new option for... Read more
Zoledronic acid has received a positive approval recommendation in Europe for use in the treatment of osteoporosis, putting it one step closer to final approval by the European Commission. The once-yearly intravenous medication is a bisphosphonate that inhibits the process of bone breakdown. Zoledronic acid is now FDA-approved in the U.S... Read more